Disposable Endoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2032

Disposable Endoscopes Market by Product (Bronchoscopes, Gastroscopes, Duodenoscopes, Laryngoscope, and Others), Application (Pulmonology, Gastroenterology, Urology, ENT, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing instances of cross-contamination and infections, increasing prevalence of chronic conditions, and rising product developmental activities globally.

The disposable endoscopes market was valued at USD 2.65 billion in 2024, growing at a CAGR of 10.19% during the forecast period from 2025 to 2032 to reach USD 5.74 billion by 2032. The increasing instances of cross-contamination and infections in healthcare settings are driving the demand for safer alternatives like disposable endoscopes, which eliminate the need for reprocessing and reduce infection risks. Alongside this, the rising prevalence of chronic conditions such as gastrointestinal, respiratory, and urological disorders is leading to a higher volume of diagnostic and therapeutic endoscopic procedures. Additionally, ongoing product development activities, including advancements in imaging, portability, and AI integration, are enhancing device performance and usability. Collectively, these factors are significantly boosting the overall market growth of disposable endoscopes worldwide during the forecast period from 2025 to 2032.

Disposable Endoscopes Market Dynamics:

According to data from the World Health Organization (2022), for every 100 patients admitted to acute-care hospitals, approximately 7 in high-income countries and 15 in low- and middle-income countries acquire at least one healthcare-associated infection (HAI) during their hospital stay. Furthermore, the same report estimates that around 136 million cases of healthcare-associated, antibiotic-resistant infections occur globally each year.

Reusable endoscopes, despite undergoing reprocessing, continue to pose a significant risk of transmitting infections such as Clostridioides difficile, Pseudomonas aeruginosa, and drug-resistant organisms like MRSA, VRE, and CRE. In contrast, disposable endoscopes offer a sterile, single-use solution that eliminates the risk of disinfection failures. This makes them particularly suitable for high-risk environments such as intensive care units (ICUs) and emergency departments. Consequently, the need for improved infection control and safer, more efficient clinical practices is fueling the growing demand for disposable endoscopes.

In addition, the increasing prevalence of respiratory, gastrointestinal, and urological conditions is further driving the disposable endoscope market. According to the World Gastroenterology Organization (2023), approximately 49% of females and 36.6% of males globally meet the criteria for at least one functional gastrointestinal disorder. Similarly, data from the Urology Foundation (2023) indicate that around one in two individuals in the United Kingdom experiences a urological condition. These rising disease rates are contributing to increased demand for diagnostic and therapeutic procedures, thereby boosting the need for disposable endoscopic solutions.

While reusable endoscopes are effective, they require complex, time-consuming, and costly reprocessing protocols, which also carry a risk of cross-contamination. With a growing number of endoscopic procedures being performed in outpatient settings, ambulatory surgical centers, and emergency departments, disposable endoscopes offer a practical alternative. They reduce infection risk, shorten turnaround times, and enhance patient throughput.

Moreover, ongoing product development efforts by key industry players are supporting market expansion. For example, in May 2022, Ambu received European regulatory approval for its Ambu® aScope™ 5 Broncho, a line of sterile, single-use bronchoscopes.

Therefore, the factors outlined above are expected to collectively drive the growth of the disposable endoscopes market during the forecast period from 2025 to 2032.

However, despite these advantages, certain limitations could hinder market growth. As single-use devices, disposable endoscopes contribute to medical waste, raising environmental and sustainability concerns. Additionally, their limited suitability for complex procedures may restrict adoption in some clinical settings, serving as key constraints on broader market expansion.

Disposable Endoscopes Market Segment Analysis:

Disposable Endoscopes Market by Product (Bronchoscopes, Gastroscopes, Duodenoscopes, Laryngoscope, and Others), Application (Pulmonology, Gastroenterology, Urology, ENT, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the products segment of disposable endoscopes, the bronchoscopes category is expected to have a significant revenue share in the year 2024. This can be ascribed to their advantages, such as the use of bronchoscopes in the diagnosis and treatment of tumors and bronchial cancers, airway blockage (obstruction), narrowed areas in the airways, and interstitial pulmonary diseases, among others.

Another key aspect contributing in the growing demand for bronchoscopes is that it also comprises of increased detection and improved access, reaching to the most distant regions of the lungs, earlier diagnosis of lung tumors, better treatment decisions, reduced risk associated with complications, and eliminating the risk associated with invasive surgeries, all of the advantages possible due to the presence of navigational bronchoscopy.

Given the advantages associated with navigational bronchoscopy, there has been increasing acceptance among end users, which in turn has led to a rise in the number of new product launches in the market. For example, in April 2023, Verathon, a leading global medical device company, announced the launch of the BFlex™ 2, the next generation of its single-use bronchoscope portfolio. The upgraded BFlex 2 series features four scope sizes and incorporates enhanced capabilities aimed at helping clinicians deliver improved care for both adult and pediatric patients across various hospital settings.

Therefore, driven by these advancements and growing clinical adoption, the bronchoscopes segment is anticipated to experience significant growth, thereby contributing substantially to the overall expansion of the disposable endoscopes market during the forecast period from 2025 to 2032.

North America is expected to dominate the overall disposable endoscopes market:

North America is expected to lead the global disposable endoscopes market in 2024, driven by several key factors, including the rising incidence of healthcare-associated infections (HAIs), the growing prevalence of chronic conditions such as urological and gastrointestinal disorders, and continued advancements in healthcare technology.

One of the primary drivers in the region is the increasing risk of cross-contamination associated with reusable endoscopes. According to data from the Centers for Disease Control and Prevention (CDC, 2024), approximately 1 in 31 hospital patients in the United States acquires at least one healthcare-associated infection. Similarly, recent data from the Provincial Infection Control Network of British Columbia (2025) reported that in Canada, 1 in 9 hospital patients contract an HAI, with over 220,000 such cases occurring annually. These statistics underscore the growing threat of infection in clinical settings, especially where reusable devices are used. Disposable endoscopes, being sterile and single-use, eliminate the risk of cross-contamination and are increasingly preferred in high-risk environments such as ICUs and emergency departments.

Additionally, technological innovations and regulatory support are strengthening the regional market. North America has witnessed a surge in product development and regulatory approvals, supported by a well-established healthcare infrastructure and the strong presence of key medical device companies. These conditions create a favorable ecosystem for market expansion.

For example, in May 2024, Olympus Corporation announced the launch of the DVM-B2 Digital Video Monitor, an integrated video processor and monitor specifically designed for use with single-use endoscopes. This system supports applications in bronchoscopy and ENT procedures and is compatible with Olympus's H-SteriScope™ Single-use Flexible Bronchoscopes and E-SteriScope™ Single-use Flexible Rhinolaryngoscopes. The device, manufactured by Hunan Vathin Medical Instruments Co., Ltd., is distributed exclusively by Olympus America, Inc., further reinforcing the company's commitment to advancing disposable endoscopy solutions in the region.

Moreover, increased awareness of infection control, favorable reimbursement frameworks, and ongoing partnerships and commercialization strategies among major industry players are expected to accelerate market growth further.

In conclusion, the convergence of rising HAI rates, technological innovation, growing demand for safer diagnostic tools, and strong regional healthcare investment is expected to make North America a dominant force in the disposable endoscopes market during the forecast period from 2025 to 2032. 

Disposable Endoscopes Market key players:

Some of the key market players operating in the disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Baxter, Teleflex Incorporated, Flexicare Medical Limited, AUG Medical, NeoScope Inc., Xenocor Inc., 3NT Medical, Corinth MedTech, Inc., PENTAX Medical, Daichuan Medical, Omnivision, Verathon, and others.

Recent Developmental Activities in the Disposable Endoscopes Market:

• In September 2023, Olympus Corporation launched the Vathin E-SteriScope single-use flexible video rhinolaryngoscope for use in diagnostic and therapeutic otorhinolaryngological procedures.
• In April 2023, Verathon, a global leader in airway management solutions, unveiled the GlideScope® Spectrum™ QC featuring QuickConnect™ technology. This extensive lineup of single-use video laryngoscopes showcases a magnetic connector coupled with improvements in image quality, designed to support rapid and effective airway management.
• In November 2022, PROACT Medical launched a new range of gas sampling lines along with their new line of single-use laryngoscopes to improve patient care in the European market.

Key takeaways from the disposable endoscopes market report study:

• Market size analysis for current disposable endoscopes market size (2024), and market forecast over 8 years (2025 to 2032)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the disposable endoscopes market
• Various opportunities available for the other competitors in the disposable endoscopes market space
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current disposable endoscopes market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the disposable endoscopes market growth in the future?

Target audience who can benefit from this disposable endoscopes market report study:

• Disposable endoscopes product providers
• Research organizations and consulting companies
• Disposable endoscopes-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in disposable endoscopes
• Various end-users who want to know more about the disposable endoscopes market and the latest developments in the disposable endoscopes market

Frequently Asked Questions for the Disposable Endoscopes Market:

1. What are disposable endoscopes?

• The disposable endoscopes, also known as single-use endoscopes, are medical devices designed to perform minimally invasive diagnostic and therapeutic procedures within the body. Unlike reusable endoscopes, they are discarded after a single use, eliminating the need for sterilization and reprocessing.

2. What is the market for disposable endoscopes?

• The disposable endoscopes market was valued at USD 2.65 billion in 2024, growing at a CAGR of 10.19% during the forecast period from 2025 to 2032 to reach USD 5.74 billion by 2032.

3. What are the drivers for the disposable endoscopes market?

• The increasing instances of cross-contamination and infections in healthcare settings are driving the demand for safer alternatives like disposable endoscopes, which eliminate the need for reprocessing and reduce infection risks. Alongside this, the rising prevalence of chronic conditions such as gastrointestinal, respiratory, and urological disorders is leading to a higher volume of diagnostic and therapeutic endoscopic procedures. Additionally, ongoing product development activities, including advancements in imaging, portability, and AI integration, are enhancing device performance and usability. Collectively, these factors are significantly boosting the overall market growth of disposable endoscopes worldwide during the forecast period from 2025 to 2032.

4. Who are the key players operating in the disposable endoscopes market?

• Some of the key market players operating in the disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Baxter, Teleflex Incorporated, Flexicare Medical Limited, AUG Medical, NeoScope Inc., Xenocor Inc., 3NT Medical, Corinth MedTech, Inc., PENTAX Medical, Daichuan Medical, Omnivision, Verathon, and others.

5. Which region has the highest share in the disposable endoscopes market?

• Among all the regions, North America is expected to dominate the disposable endoscopes market in the year 2024. This can be attributed to several factors, such as rising instances of cross-contamination and chronic conditions such as urological and gastrointestinal disorders. Additionally, the enhanced technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments are other major factors that are expected to drive the market for disposable endoscopes during the forecast period from 2025 to 2032.

This product will be delivered within 2 business days.